US|EN
Select your region & language
Our content and services may vary by location.
US|EN
Back
Smiling employee in a conversation with a colleague in the office
Smiling employee in a conversation with a colleague in the office
ID: 130477

Interim Global Clinical Program Director

  • Pharma & Biotech
  • Asap
  • Phase I-IV, Patient Safety, Oncology, Immunology
  • K-Recruiting GmbH
Contact:

Julius Strack

+49 89 1890998-614

julius.strack@k-recruiting.com

Overview

Availability
Asap, full-time, onsite & remote
Qualification
Study of Human Medicine, Medical license
Language Skills
German (native), English (business fluent)
Relevant Expertise
Global Clinical Program Manager, Phase I-IV, Early Development, Development Plans, Patient Safety, Program Management, Oncology, Immunology, Pharma & B

Key-Facts

  • Successfully completed various clinical development projects

  • Global Clinical Program Director with more than 30 years of experience

  • Design, implementation, and successful execution of Clinical Development Plans; Phase I-IV

  • Deep knowledge of all aspects in conducting clinical trials

  • Excellent communication skills with extensive experience in data presentation, medical leader in interaction with internal and external stakeholders, strong problem-solving skills, self-motivated and pro-active

Extract from previous activities

Pharmaceutical Company, Germany

Interim Global Clinical Program Director

  • Responsible & accountable for global clinical studies as part of a therapeutic program, inclusive strategy

  • Created clinical development plans and regulatory documents (briefing books, IND) for new indications leading to open INDs

  • Global lead for the clinical development of a monoclonal antibody in dermatological and rheumatological indications

  • Reviewed and approved marketing materials

  • Developed, set up and conducted of non-interventional studies

  • Managed and oversaw data review, participates in safety review

  • Responsible for overseeing Project timelines for each project

Biotechnological Company, Germany

Senior Clinical Program Director TA Oncology

  • Established early clinical development plans

  • Accountable for the strategic planning, oversight and execution of the program, including the continuous monitoring of the risk-benefit ratio of the clinical development project

  • Global lead for the early clinical development of a compound in oncology (solid tumors)

  • Medical monitoring

  • Oversaw medical project budgets for the respective project(s)

  • Acted as the key medical point of contact for internal and external stakeholders including providing medical leadership to the cross-functional teams

Pharmaceutical Company, Switzerland

Principal Medical Expert

  • Principal clinical lead for new drugs and responsible for the respective clinical development plans (Phase IIV)

  • Designed, executed, monitored and reported the clinical development program incl. life cycle management plan (Phase IIIb/IV trials) for a biological product

  • Evaluated new indications, development and presentation of respective development scenarios

  • Clinical lead for the FDA approval of a biological product for four indications

  • Contributed to the publications related to clinical data and presentation of results at internal and external meeting

  • Contributed to the medical monitoring activities of ongoing studies